Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine
Alberto Grandi(Toscana Life Sciences), Guido Grandi(University of Trento)
Cited by 11
Related Papers
ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer
|Oncotarget|2016|33
A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins
|Journal of Proteomics|2011|11
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine
|Research Square|2023|5
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine
|bioRxiv (Cold Spring Harbor Laboratory)|2021|3